- Evolving legal and regulatory landscapes
- Carbon pricing regulations (potential supply chain impacts)
- Supplier actions and expectations
- Availability of biobased materials for low-carbon products
- Reputation as a result of striving to meet sustainability targets
- Extreme weather events that may have an acute physical and chronic physical risk on our supply chain or direct operations
SHL Medical AG
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, SHL Medical AG disclosed greenhouse gas emissions of 290.4K tCO2e/year. By scope: Scope 1: 440 tCO2e/year; Scope 2: 43.3K tCO2e/year; Scope 3: 246.6K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
290.4K tCO2e/year
2023
Renewable Energy
12%
of total energy
Waste
5.2K tons/year
2023
Energy Use
87 GWh/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 440 tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 43.3K tCO2e/year |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 246.6K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- 2.6% reduction in GHG emissions (Scope 1, 2 and 3) versus 2022
- 12% share of renewable electricity
- 74% of waste recycled
- Total Scope 3 GHG emissions reduced by -33% per unit sold compared to 2022 base year
🎯 Climate & Sustainability Targets
🔜 Short-term
- Recycle >80% of our waste by 2025
- 100% of new products to adhere to eco-design principles by 2025
📅 Medium-term
- Reduce total generated waste by 20% by 2030
- Reduce absolute Scope 1 and 2 GHG emissions by -42% by 2030
- Reduce Scope 3 GHG emissions by -51.6% per million units sold by 2030
- 30% share of women in senior management roles by 2025
- 100% of employees trained on ethics annually by 2025
🔭 Long-term
- Empower 8 million patients to live independently by 2030
- <1 lost time injuries per million of working hours by 2030
- >7.8 employee engagement score by 2030
- 100% renewable electricity in all our sites by 2030
- Reduce 30% of environmental impact per device by 2030
🌱 ESG Focus Areas
Patient health and independenceReducing our ecological footprintEnsuring responsible business practices